[{"Assets_0_Q3_USD":311937000.0,"CommonStockSharesOutstanding_0_Q3_shares":52400709.0,"EarningsPerShareBasic_1_Q3_USD":0.14,"EarningsPerShareBasic_3_Q3_USD":0.3,"EarningsPerShareDiluted_1_Q3_USD":0.13,"EarningsPerShareDiluted_3_Q3_USD":0.28,"NetIncomeLoss_1_Q3_USD":7171000.0,"NetIncomeLoss_3_Q3_USD":14848000.0,"StockholdersEquity_0_Q3_USD":261417000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":54709749.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":52315642.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":52389012.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":50321640.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]